Generic placeholder image

Current Vascular Pharmacology

Author(s): Guangyao Zhai, Biyang Zhang, Jianlong Wang, Yuyang Liu and Yujie Zhou*

DOI: 10.2174/1570161120666220721094739

DownloadDownload PDF Flyer Cite As
Prognostic Value of Pericardial Effusion Size in Patients with Acute Heart Failure

Page: [508 - 516] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: Pericardial Effusion (PEf) can occur with Acute Heart Failure (AHF).

Objective: To evaluate the effect of PEf size on the prognosis of patients with AHF.

Methods: According to the maximum size of PEf, all patients were divided into five groups. The primary outcome was in-hospital mortality. The independent effect of PEf size was determined by binary logistic regression analysis. The curve in line with the overall trend was drawn by local weighted regression (Lowess).

Results: We included 192 patients with AHF complicated by PEf. As PEf size increased, in-hospital mortality increased significantly (Group 5 vs. Group 1: 34.8 vs. 8.9% p=0.042). After adjusting for confounders, there was no significant association between PEf groups and in-hospital mortality (Group 5 vs. Group 1: odd ratio (OR), 95% confidence interval (CI): 2.72, 0.41-18.22, p=0.298). However, when PEf size was analysed as a continuous variable, an independent association between increased risk of inhospital mortality and PEf size was observed (OR, 95% CI: 1.08, 1.00-1.16, p=0.037). The Lowess curve showed a positive relationship between PEf size and in-hospital mortality. Furthermore, as PEf groups increased, the length of hospital stay (Group 5 vs. Group 1 median and interquartile range: 16, 14-21 vs. 13, 8-17 days, p<0.001) was significantly prolonged. An association between PEf size with acute kidney injury (AKI) was not observed.

Conclusion: The PEf size was independently associated with the increased risk of in-hospital mortality in patients with AHF.

Keywords: Pericardial effusion, acute heart failure, in-hospital mortality, acute kidney injury, the length of hospital stay, confidence interval.

Graphical Abstract

[1]
Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62(16): e147-239.
[http://dx.doi.org/10.1016/j.jacc.2013.05.019] [PMID: 23747642]
[2]
Killip T. Epidemiology of congestive heart failure. Am J Cardiol 1985; 56(2): 2A-6A.
[http://dx.doi.org/10.1016/0002-9149(85)91198-1] [PMID: 4014050]
[3]
Paul O, Vawter GF, Schweitzer AW, Hass GM. Pathological changes in congestive heart failure; a review of findings in fifty cases. AMA Arch Pathol 1957; 64(4): 363-81.
[PMID: 13457593]
[4]
Spadick DH. Chronic and constrictive pericarditis. New York: Grune and Stratton Inc 1964.
[5]
Winters WL Jr, Carter BL, Stauffer HM, Soloff LA. Pericardial effusion in congestive heart failure. Dis Chest 1961; 40(1): 82-6.
[http://dx.doi.org/10.1378/chest.40.1.82] [PMID: 13785954]
[6]
Borlaug BA, Jaber WA, Ommen SR, Lam CS, Redfield MM, Nishimura RA. Diastolic relaxation and compliance reserve during dynamic ex-ercise in heart failure with preserved ejection fraction. Heart 2011; 97(12): 964-9.
[http://dx.doi.org/10.1136/hrt.2010.212787] [PMID: 21478380]
[7]
Borlaug BA, Reddy YNV. The Role of the pericardium in heart failure: Implications for pathophysiology and treatment. JACC Heart Fail 2019; 7(7): 574-85.
[http://dx.doi.org/10.1016/j.jchf.2019.03.021] [PMID: 31248569]
[8]
Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J 2000; 139(5): 918-23.
[http://dx.doi.org/10.1016/S0002-8703(00)90026-7] [PMID: 10783228]
[9]
Figueras J, Barrabés JA, Serra V, et al. Hospital outcome of moderate to severe pericardial effusion complicating ST-elevation acute myocar-dial infarction. Circulation 2010; 122(19): 1902-9.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.934968] [PMID: 20975001]
[10]
Albani S, Fabris E, Stolfo D, et al. Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: A 10-year single-centre experience. Eur Heart J Acute Cardiovasc Care 2019; 2048872619884858.
[11]
Mitiku TY, Heidenreich PA. A small pericardial effusion is a marker of increased mortality. Am Heart J 2011; 161(1): 152-7.
[http://dx.doi.org/10.1016/j.ahj.2010.10.007] [PMID: 21167348]
[12]
Fröhlich GM, Keller P, Schmid F, et al. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J 2013; 34(19): 1414-23.
[http://dx.doi.org/10.1093/eurheartj/eht006] [PMID: 23355650]
[13]
Santas E, Sandino J, Chorro FJ, et al. Prognostic implications of pericardial effusion in acute heart failure: Does size matter? Int J Cardiol 2015; 184: 259-61.
[http://dx.doi.org/10.1016/j.ijcard.2015.02.052] [PMID: 25726903]
[14]
Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25(7): 587-610.
[http://dx.doi.org/10.1016/j.ehj.2004.02.002] [PMID: 15120056]
[15]
Klein AL, Abbara S, Agler DA, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular im-aging of patients with pericardial disease: Endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular com-puted tomography. J Am Soc Echocardiogr 2013; 26(9): 965-1012.e15.
[http://dx.doi.org/10.1016/j.echo.2013.06.023] [PMID: 23998693]
[16]
Miller AJ, Pick R, Johnson PJ. The rates of formation of cardiac lymph and pericardial fluid after the production of myocardial venous con-gestion in dogs. Lymphology 1972; 5(4): 156-60.
[PMID: 4647281]
[17]
Cui Y. The role of lymphatic vessels in the heart. Pathophysiology 2010; 17(4): 307-14.
[http://dx.doi.org/10.1016/j.pathophys.2009.07.006] [PMID: 19942415]
[18]
Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 2017; 70(20): 2476-86.
[http://dx.doi.org/10.1016/j.jacc.2017.08.074] [PMID: 29141781]
[19]
Moore TD, Frenneaux MP, Sas R, et al. Ventricular interaction and external constraint account for decreased stroke work during volume loading in CHF. Am J Physiol Heart Circ Physiol 2001; 281(6): H2385-91.
[http://dx.doi.org/10.1152/ajpheart.2001.281.6.H2385] [PMID: 11709403]
[20]
Yu SB, Zhao QY, Huang H, et al. Prognosis investigation in patients with chronic heart failure and pericardial effusion. Chin Med J (Engl) 2012; 125(5): 882-7.
[PMID: 22490591]
[21]
Sugiura T, Kumon Y, Kataoka H, Matsumura Y, Takeuchi H, Doi Y. Asymptomatic pericardial effusion in patients with rheumatoid arthritis. Cardiology 2008; 110(2): 87-91.
[http://dx.doi.org/10.1159/000110485] [PMID: 17975311]
[22]
Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol 2011; 34(10): 593-8.
[http://dx.doi.org/10.1002/clc.20936] [PMID: 21928406]
[23]
Airaghi L, Montori D, Santambrogio L, Miadonna A, Tedeschi A. Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med 2000; 247(6): 731-5.
[http://dx.doi.org/10.1046/j.1365-2796.2000.00693.x] [PMID: 10886496]
[24]
Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure--the whys and wherefores. Heart Fail Rev 2006; 11(1): 83-92.
[http://dx.doi.org/10.1007/s10741-006-9196-2] [PMID: 16819581]
[25]
Dixon DL, Griggs KM, Bersten AD, De Pasquale CG. Systemic inflammation and cell activation reflects morbidity in chronic heart failure. Cytokine 2011; 56(3): 593-9.
[http://dx.doi.org/10.1016/j.cyto.2011.08.029] [PMID: 21924921]
[26]
Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325(5): 293-302.
[http://dx.doi.org/10.1056/NEJM199108013250501] [PMID: 2057034]
[27]
Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35(3): 681-9.
[http://dx.doi.org/10.1016/S0735-1097(99)00608-7] [PMID: 10716471]
[28]
Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R. Renal dysfunction in acute and chronic heart failure: Prevalence, inci-dence and prognosis. Heart Fail Rev 2012; 17(2): 133-49.
[http://dx.doi.org/10.1007/s10741-012-9306-2] [PMID: 22426973]
[29]
de Silva R, Nikitin NP, Witte KK, et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventric-ular systolic dysfunction: Contributing factors and relationship to prognosis. Eur Heart J 2006; 27(5): 569-81.
[http://dx.doi.org/10.1093/eurheartj/ehi696] [PMID: 16364971]
[30]
Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B. Prevalence and impact of worsening renal function in patients hospital-ized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006; 27(10): 1216-22.
[http://dx.doi.org/10.1093/eurheartj/ehi859] [PMID: 16624834]
[31]
Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43(1): 61-7.
[http://dx.doi.org/10.1016/j.jacc.2003.07.031] [PMID: 14715185]
[32]
Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8(3): 136-41.
[http://dx.doi.org/10.1054/jcaf.2002.125289] [PMID: 12140805]
[33]
Kociol RD, Greiner MA, Hammill BG, et al. Long-term outcomes of medicare beneficiaries with worsening renal function during hospitaliza-tion for heart failure. Am J Cardiol 2010; 105(12): 1786-93.
[http://dx.doi.org/10.1016/j.amjcard.2010.01.361] [PMID: 20538131]
[34]
Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26(11): 1115-40.
[http://dx.doi.org/10.1093/eurheartj/ehi204] [PMID: 15901669]